Cite
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
MLA
Aytekin, Alp, et al. “Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.” Circulation, vol. 142, no. 24, Dec. 2020, pp. 2329–37. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.120.050244.
APA
Aytekin, A., Ndrepepa, G., Neumann, F.-J., Menichelli, M., Mayer, K., Wöhrle, J., Bernlochner, I., Lahu, S., Richardt, G., Witzenbichler, B., Sibbing, D., Cassese, S., Angiolillo, D. J., Valina, C., Kufner, S., Liebetrau, C., Hamm, C. W., Xhepa, E., Hapfelmeier, A., & Sager, H. B. (2020). Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation, 142(24), 2329–2337. https://doi.org/10.1161/CIRCULATIONAHA.120.050244
Chicago
Aytekin, Alp, Gjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, Katharina Mayer, Jochen Wöhrle, Isabell Bernlochner, et al. 2020. “Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.” Circulation 142 (24): 2329–37. doi:10.1161/CIRCULATIONAHA.120.050244.